New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Selective T-Cell Depletion Improves Engraftment, Reduces GVHD in Pediatric/AYA Leukemia

Selective T-Cell Depletion Improves Engraftment, Reduces GVHD in Pediatric/AYA Leukemia

May 3, 2018Jason HarrisEliminating T cells carrying alpha and beta chains of the T-cell receptor reduced the risk for graft-versus-host-disease while producing "excellent" engraftment kineti
World medicine November 21,2023
Selective T-Cell Depletion Improves Engraftment, Reduces GVHD in Pediatric/AYA Leukemia

Selective T-Cell Depletion Improves Engraftment, Reduces GVHD in Pediatric/AYA Leukemia

May 3, 2018Jason HarrisEliminating T cells carrying alpha and beta chains of the T-cell receptor reduced the risk for graft-versus-host-disease while producing "excellent" engraftment kineti
World medicine November 21,2023
Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

April 17, 2017Ariela KatzThe international CanStem303C trial is evaluating the combination of napabucasin, the most advanced cancer stemness inhibitor in development, with FOLFIRI chemotherapy in pati
World medicine November 21,2023
Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

April 17, 2017Ariela KatzThe international CanStem303C trial is evaluating the combination of napabucasin, the most advanced cancer stemness inhibitor in development, with FOLFIRI chemotherapy in pati
World medicine November 21,2023
Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

June 14, 2016Vaishalee Kenkre, MD, Walter Longo, MDPeiman Hematti, MDThis pilot trial is the first of its type to investigate T cell receptor alpha/beta-depleted and CD19-depleted haploidentical stem
World medicine November 21,2023
Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

June 14, 2016Vaishalee Kenkre, MD, Walter Longo, MDPeiman Hematti, MDThis pilot trial is the first of its type to investigate T cell receptor alpha/beta-depleted and CD19-depleted haploidentical stem
World medicine November 21,2023
No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

August 7, 2015Colleen S. Delaney, MD, MSCThe perception that cord blood is an inferior source of stem cells is simply not accurate and may result in delays in lifesaving treatment for patients.Colleen
World medicine November 21,2023
No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

August 7, 2015Colleen S. Delaney, MD, MSCThe perception that cord blood is an inferior source of stem cells is simply not accurate and may result in delays in lifesaving treatment for patients.Colleen
World medicine November 21,2023
Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

December 11, 2011Ben LeachStudy finds that peripheral blood stem cell (PBSC) transplants increase the incidence of graft-versus-host disease (GVHD).A new study has found that peripheral blood stem cel
World medicine November 21,2023
Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

December 11, 2011Ben LeachStudy finds that peripheral blood stem cell (PBSC) transplants increase the incidence of graft-versus-host disease (GVHD).A new study has found that peripheral blood stem cel
World medicine November 21,2023
Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

November 15, 2011Bonnie GillisWilliam I. Bensinger, MD, tackles the complex subject of the role of hematopoietic stem cell transplantation (HSCT), including when to transplant and whether to use allog
World medicine November 21,2023
Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

November 15, 2011Bonnie GillisWilliam I. Bensinger, MD, tackles the complex subject of the role of hematopoietic stem cell transplantation (HSCT), including when to transplant and whether to use allog
World medicine November 21,2023
First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

February 11, 2016Greg KenneltyKelly JohnsonManish A. Shah, MD, discusses the BRIGHTER trial, which is investigated BBI608 as a second-line treatment for patients with gastric and gastroesophageal junc
World medicine November 21,2023
First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

February 11, 2016Greg KenneltyKelly JohnsonManish A. Shah, MD, discusses the BRIGHTER trial, which is investigated BBI608 as a second-line treatment for patients with gastric and gastroesophageal junc
World medicine November 21,2023
Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

June 21, 2018Gina ColumbusMax Wicha, MD, shares insight on the intriguing research being conducted on breast cancer stem cells.Max Wicha, MD, associate professor of oncology and urology at Johns Hopki
World medicine November 21,2023
Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

June 21, 2018Gina ColumbusMax Wicha, MD, shares insight on the intriguing research being conducted on breast cancer stem cells.Max Wicha, MD, associate professor of oncology and urology at Johns Hopki
World medicine November 21,2023
Gaining Ground: Personal Losses Help Drive Pioneer in Stem Cell Study

Gaining Ground: Personal Losses Help Drive Pioneer in Stem Cell Study

December 12, 2012Beth Fand IncollingoAn interview with Jenny C. Chang, MB BChir, MD, who broke new ground in cancer research when she identified and patented a 493-gene signature for breast cancer.Pho
World medicine November 21,2023
Gaining Ground: Personal Losses Help Drive Pioneer in Stem Cell Study

Gaining Ground: Personal Losses Help Drive Pioneer in Stem Cell Study

December 12, 2012Beth Fand IncollingoAn interview with Jenny C. Chang, MB BChir, MD, who broke new ground in cancer research when she identified and patented a 493-gene signature for breast cancer.Pho
World medicine November 21,2023
Subcutaneous Daratumumab Offers Convenience for Patients With Multiple Myeloma

Subcutaneous Daratumumab Offers Convenience for Patients With Multiple Myeloma

June 21, 2020Denise MyshkoNearly 5 years after its approval for patients with multiple myeloma, daratumumab is now available in a formulation that can be administered in a fraction of the time require
World medicine November 21,2023
Subcutaneous Daratumumab Offers Convenience for Patients With Multiple Myeloma

Subcutaneous Daratumumab Offers Convenience for Patients With Multiple Myeloma

June 21, 2020Denise MyshkoNearly 5 years after its approval for patients with multiple myeloma, daratumumab is now available in a formulation that can be administered in a fraction of the time require
World medicine November 21,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com